Statin treatment may be beneficial to both the kidney and the heart [2]

Peritoneal Dialysis International

Volumn 27, Issue 2, 2007, Pages 215-216

  Athyros, V G ^a   Karagiannis, A ^a   Liberopoulos, E N ^b   Elisaf, M ^b   Mikhailidis, D P ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; URIC ACID;

CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; LETTER; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; POST HOC ANALYSIS; PRIORITY JOURNAL; RISK REDUCTION; UNIVARIATE ANALYSIS; URIC ACID BLOOD LEVEL;

EID: 34249064578     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700224     Document Type: Letter

References (4)

1. Shurraw S, Tonelli M. Statins for treatment of dyslipidemia in chronic kidney disease. Perit Dial Int 2006; 26:523-39.
2. Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study. J Clin Pathol 2004; 57:728-34.
3. Athyros VG, Elisaf M, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, et al; GREACE Study Collaborative Group. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Am J Kidney Dis 2004; 43:589-99.
4. Athyros VG, Mikhailidis DP, Liberopoulos EN, Kakafika AI, Karagiannis A, Papageorgiou AA, et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant 2006 (23 September 2006; epub ahead of print, doi:10.1093/ndt/gf1538).